Refine by
Prostate Cancer Suppliers & Manufacturers
86 companies found
based inIrvine, CALIFORNIA (USA)
Established in 2011, Pathnostics is driven to pioneer a better future for physicians, patients, and the healthcare system with solutions that transform diagnostic and therapeutic dilemmas. Core capabilities in infectious disease and cancer ...
Prostate biopsies are performed when results from initial tests, like a prostate-specific antigen (PSA) blood test or digital rectal exam, indicate the possibility of prostate ...
based inSunnyvale, CALIFORNIA (USA)
Olympia Diagnostics is an In Vitro Diagnostics (IVD) company focusing on development and commercialization of the most advanced breakthrough products for cancer diagnosis and prognosis. We developed a proprietary biomarker discovery platform to ...
A prognostic test kit quantitatively measures the expression levels of a panel of cancer recurrence-associated biomarkers in patient urine sample or biopsy tissue sample to predict cancer recurrence and patient ...
based inSaint-Prex, SWITZERLAND
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Ferring is a leader in reproductive medicine and maternal health, and in specialty ...
GONAPEPTYL / DECAPEPTYL* (triptorelin acetat) is a solution for injection containing 0.1 mg/1 ml of triptorelin acetate (per prefilled syringe). It is indicated for the down regulation of the pituitary before and during controlled ovarian ...
based inSan Francisco, CALIFORNIA (USA)
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Cytovale’s investigational IntelliSep test is pioneering a new way of quickly and accurately ...
based inToronto, ONTARIO (CANADA)
Focal Healthcare is a world-class medical device company dedicated to improving the physician and patient experience from prostate cancer diagnosis to treatment. Throughout his career, Chicuong realized that there were many inefficiencies, ...
Prostate cancer is the only solid cancer still diagnosed through random sampling. Get accurate and meaningful results faster with a targeted approach. Thoughtfully engineered, the semi-robotic arm ...
based inFederal Way, WASHINGTON (USA)
Established in 1987, DiagnosTechs was the first laboratory to introduce saliva hormone testing into routine clinical practice. In 1995, DiagnosTechs added saliva and stool-based gastrointestinal and food sensitivity testing, which expanded the level ...
based inWoburn, MASSACHUSETTS (USA)
We are leading the way in developing green, enabling biotechnology and nanotechnology drug delivery platforms and enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and ...
Prostate cancer is the most prevalent cancer among men, and it is the second leading cause of cancer death among men in the United States. More than 500,000 cases are diagnosed ...
based inxiamen, CHINA
XIAMEN SPACEGEN Co., Ltd. is a high-tech molecular diagnostic biology enterprise integrating R&D, production, sales and service. The company leads technological innovation guided by clinical needs ，providing high-quality and accessible molecular ...
Detection Gene:BRCA1, BRCA2 whole exome sequencing and Includes ±20 bp regions at exon-intron junctions. Detection Significance:Predicting prognosis ;Auxiliary diagnosis;Guiding the selection of ...
based inSunnyvale, CALIFORNIA (USA)
Embolx is an emerging commercial-stage medical device company in Silicon Valley developing microcatheters for arterial embolization procedures. Embolx is committed to dramatically improving the treatment of a variety of conditions including ...
based inNew York City, NEW YORK (USA)
Led by a team of experts in the fields of life sciences, oncology, pathology, technology, machine learning, and healthcare, Paige strives to transform cancer diagnostics. We make it possible not only to provide additional information from digital ...
The Paige Prostate Suite is comprised of Paige Prostate Detect, Paige Prostate Grade & Quantify, and Paige Prostate Perineural Invasion. The AI applications available in the Paige Prostate Suite aim to assist in efficiencies of reads and reduce ...
based inGolden, COLORADO (USA)
At Vitro Biopharma, our goal is to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market, and ultimately, to address well-established multi-billion-dollar ...
High passage capabilities. Expands in VitroPlusIII Low Serum, Complete Medium (Vitro Biopharma, Cat. No. PC00B1–optimized for high growth rates, reduced doubling times, healthy cells, and stability). Able to grow in low oxygen (1% - 5% O2). ...
based inHelsinki, FINLAND
MVision AI is a health‑tech company that provides AI-powered software to automate and standardise key steps in radiotherapy planning, helping clinics work more efficiently while keeping clinicians in control of treatment decisions. MVision AI ...
Dose+ is an innovative AI-powered solution tailored for radiotherapy planning, particularly for prostate and pelvic lymph node treatments. Utilizing machine learning, it offers personalized patient-specific dose predictions to ...
based inCarlsbad, CALIFORNIA (USA)
TargaZyme is a clinical-stage biotechnology company based in San Diego, CA and focused on the research and development of disruptive and novel, off-the-shelf T-Cell products that are aimed at improving the efficacy of T-cell therapies by delivering ...
TILs are part of the body’s natural response to cancer:The cells of the immune system perform immunosurveillance while circulating throughout the bodyAs part of the normal immune response, TIL migrate to the tumor site through recognition of ...
based inNew Haven, CONNECTICUT (USA)
BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company utilizing artificial intelligence, or AI, approaches to develop transformative medicines in neuroscience and immuno-oncology. We are focused on utilizing cutting-edge ...
BXCL701 (talabostat) is an investigational, oral small molecule inhibitor of dipeptidyl peptidases (DPP)—primarily DPP 8/9 and DPP 4—which triggers inflammasome to alert and prime immune cells, leading to induction of IL-18 and ...
based inReno, NEVADA (USA)
DxDiscovery is a biotechnology Research & Development firm. The corporate goal is to develop quality, high-affinity antibodies to microbial antigens. These antibodies are incorporated into rapid POC diagnostics, or they may be developed as ...
based inMarkham, ONTARIO (CANADA)
Exact Imaging has an experienced management team that has together and individually successfully launched multiple companies and products into global markets, developed global teams and commercial infrastructures, and achieved multiple liquidity ...
ExactVu micro-ultrasound system for targeted biopsies for prostate cancer. ...
based inMilan, ITALY
Bracco is an international Group active in the healthcare sector and a leader in diagnostic imaging. It has around 3,587 employees and annual total consolidated revenues of around 1,4 billion euros, 89% of which from international sales. In the ...
based inWaynesboro, VIRGINIA (USA)
Radium Incorporated was founded in 2004 by Cam Abernethy. Through his experience and direction, he has developed many patented (and patent pending) products that support Radium’s core product goals of increasing a worker’s quality of work, safety, ...
Designed to place a foley bag connected to a catheter attached to patients undergoing radiotherapy and scans using radiopharmaceuticals over performed by nuclear medicine specialists or radiologists. The see-through container reduces exposure to ...
based inRedwood City, CALIFORNIA (USA)
Auris Health was acquired by Ethicon, part of the Johnson & Johnson Medical Devices Companies, in 2019. Over the past 50 years, the introduction of new technologies has ushered in the era of minimally invasive techniques and procedures. Despite ...
based inAurora, COLORADO (USA)
Triopsy Medical, Inc. manufacturer of Cancer Diagnosis system. Our new Triopsy approach will create opportunity across three key market segments: medical device, pathology systems, and mapping systems for more accurate diagnosis. Our novel biopsy ...
Our disruptive and innovative technology is addressing a significant and unmet need - that is, to diagnose cancer more accurately and earlier. We are targeting a well-defined market opportunity with accessible channels of ...